Literature DB >> 12956759

A morphometric study of bone marrow angiogenesis in hairy cell leukaemia with clinicopathological correlations.

Penelope Korkolopoulou1, Despina A Gribabis, Nikolaos Kavantzas, Maria K Angelopoulou, Marina P Siakantaris, Efstratios Patsouris, Athina Androulaki, Irene Thymara, Styliani I Kokoris, Maria C Kyrtsonis, Christos Kittas, Gerassimos A Pangalis.   

Abstract

Bone marrow angiogenesis has recently been implicated in the pathophysiology and course of various haematological malignancies. Little is known, however, about the significance of this phenomenon in hairy cell leukaemia (HCL). We evaluated various morphometric characteristics of microvessels, highlighted by means of anti-CD34 immunohistochemistry, in the bone marrow of 44 patients with typical HCL, before and after treatment with interferon-alpha (IFN-alpha). Overall, bone marrow from 103 HCL patients and 20 controls was examined. Microvessel density (MVD) and several size- and shape-related parameters were quantified in the region of most intense vascularization using image analysis. MVD, size-related parameters and the percentage of branching microvessels were higher in HCL than in controls. Likewise, perimeter counts were higher in partial/non-responders than in complete responders. Achievement of complete response was accompanied by smaller calibre microvessels. IFN-alpha induced a decrease in MVD and branching values in cases with diffuse marrow involvement. In univariate analysis, progression-free survival was adversely affected by MVD, branching and major axis length. Multivariate analysis indicated that MVD/branching independently affected progression-free survival and the likelihood of complete response. Our data suggest that the generation of bone marrow microvessels indicated an increased risk of progression and IFN-alpha treatment failure in HCL. Furthermore, the prognostic significance of angiogenesis requires the concomitant assessment of MVD and the complexity of the microvascular network.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12956759     DOI: 10.1046/j.1365-2141.2003.04527.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  [Therapy-related changes of angiogenesis in Philadelphia chromosome positive chronic myelogenous leukemia].

Authors:  H M Kvasnicka; J Thiele; P Staib; K Engels; S Kriener; A Schmitt-Graeff
Journal:  Pathologe       Date:  2004-03       Impact factor: 1.011

2.  Potential role of AKT/mTOR signalling proteins in hairy cell leukaemia: association with BRAF/ERK activation and clinical outcome.

Authors:  Eleftheria Lakiotaki; Georgia Levidou; Maria K Angelopoulou; Christos Adamopoulos; Gerassimos Pangalis; George Rassidakis; Theodoros Vassilakopoulos; Gabriella Gainaru; Pagona Flevari; Sotirios Sachanas; Angelica A Saetta; Athanasia Sepsa; Maria Moschogiannis; Christina Kalpadakis; Nikolaos Tsesmetzis; Vassilios Milionis; Ilenia Chatziandreou; Irene Thymara; Panayiotis Panayiotidis; Maria Dimopoulou; Eleni Plata; Konstantinos Konstantopoulos; Efstratios Patsouris; Christina Piperi; Penelope Korkolopoulou
Journal:  Sci Rep       Date:  2016-02-19       Impact factor: 4.379

3.  The clinical impact of mean vessel size and solidity in breast carcinoma patients.

Authors:  Lars Tore Gyland Mikalsen; Hari Prasad Dhakal; Øyvind S Bruland; Bjørn Naume; Elin Borgen; Jahn M Nesland; Dag Rune Olsen
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.